Defense Attacks on Pharmacy Liens at Trial: Financial Bias, Markup Arguments, and How to Respond
James Wong — Founder & Pharmacist, LienScripts | October 22, 2024 | 10 min read
Defense counsel has a standard playbook for attacking pharmacy liens at trial: financial interest bias, inflated charges, and manufactured treatment. Understanding each attack and the established legal responses lets you protect the lien and the medication record.
This post is for informational purposes only and does not constitute legal advice.
The Defense Playbook on Pharmacy Liens
If you've litigated PI cases with pharmacy liens, you've heard variations of these arguments from defense counsel:
- "The medications were prescribed because the pharmacy and the treating physician have a financial arrangement."
- "The charges on this lien are far above what any insurance company would pay — they're inflated and shouldn't be included in special damages."
- "The plaintiff filled these prescriptions to build a case, not because they needed the medications."
These attacks are predictable. They're also largely answerable — if you know the response framework and have organized your case documentation correctly.
[!KEY] Defense counsel's three standard pharmacy lien attacks — financial bias, inflated charges, and manufactured treatment — all have established legal and factual responses, but each requires pre-trial preparation that begins with a chronological medication record tied line-by-line to physician prescriptions.
Attack 1: Financial Bias / Kickback Insinuation
The attack: Defense counsel implies or argues that the prescribing physician referred the client to a lien pharmacy in exchange for something of value — a financial relationship that compromised the clinical judgment behind the prescription decisions.
Why this is legally and factually weak:
Pharmacy lien providers do not pay referral fees to physicians. The lien arrangement is between the pharmacy and the patient — the physician's role is solely clinical. The physician prescribes medications that the patient needs; the patient's attorney enrolls the patient in a pharmacy lien to access those medications without out-of-pocket cost. The physician has no financial stake in whether the medications are filled through a lien pharmacy or a retail chain.
The response:
- Establish the independence of the prescribing decision: the physician prescribed these medications based on clinical findings, which are documented in the treatment records. The prescription decision preceded any pharmacy selection.
- If needed, the treating physician can testify that they receive no compensation from any pharmacy lien provider and that the prescriptions reflect their independent clinical judgment.
- Pharmacy lien providers are not licensed dispensaries paying for referrals — they are pharmacies operating under the same regulatory framework as any other licensed pharmacy.
Key evidence to prepare: Treating physician's deposition or declaration confirming the independence of the prescribing decision and the absence of any financial relationship with the pharmacy lien provider.
Attack 2: Inflated Charges / Unreasonable Value
The attack: Defense argues that the amounts billed on the pharmacy lien — the lien amounts per fill — are significantly higher than what Medicare, Medicaid, or private insurance would pay for the same medications, and therefore represent inflated special damages that should not be recoverable.
The legal framework:
California's reasonable value standard for medical special damages allows recovery of the reasonable value of medical services, not necessarily the amount actually paid by insurance. Howell v. Hamilton Meats & Provisions, Inc. (2011) 52 Cal.4th 541 established that when an insured plaintiff's medical bills are written down by insurance, the plaintiff is limited to the amount actually paid (the negotiated rate), not the billed amount. However, Howell explicitly addressed insured plaintiffs with written-down bills — it does not straightforwardly apply to uninsured plaintiffs or lien patients.
Corenbaum v. Lampkin (2013) 215 Cal.App.4th 1308 extended Howell principles but courts continue to work through how they apply in lien scenarios. The key distinction: a pharmacy lien patient is not an insured patient with a written-down bill. The lien amount is what the pharmacy is actually charging — it is the market rate for providing medication access to an uninsured PI patient.
The response:
- The plaintiff had no insurance coverage for these injury-related prescriptions. The lien amount is the actual charge — not an inflated billed amount subject to a contractual write-down.
- Expert testimony on the reasonable value of pharmaceutical services for uninsured patients can establish the proper comparator — not the Medicare fee schedule, which reflects a government program's negotiated rate with significant volume discounts unavailable to private providers.
- The medications themselves are not disputed — the clinical need is established. The question is the reasonable value, and the lien amount represents what a willing provider charged and what the plaintiff is contractually obligated to pay.
Key evidence to prepare: Evidence of the plaintiff's uninsured status for injury-related prescriptions; documentation that the lien amount represents an actual charge to the plaintiff, not an inflated list price subject to write-down.
Attack 3: Manufactured Treatment / Case-Building
The attack: Defense argues that the prescriptions were filled not because the plaintiff needed the medications, but to inflate special damages and create a paper trail supporting the injury claim.
Why this is the weakest of the three attacks:
This attack requires defense to argue that licensed physicians wrote clinically unwarranted prescriptions — essentially accusing the treating physicians of fraud. Most defense counsel use this argument to undermine general damages credibility rather than as a genuine fraud allegation.
The response:
- The prescriptions are in the medical records, written by licensed physicians with documented clinical findings supporting each prescription.
- Establish the treatment timeline: prescriptions correspond to specific injury diagnoses, follow clinical guidelines for the injury type, and align with the treatment trajectory documented by the treating physicians.
- The plaintiff's medication compliance actually supports, not undermines, the credibility of the injury claims — a plaintiff who is actually injured fills their prescriptions; a plaintiff manufacturing a case is more likely to not follow through.
- Offer treating physician testimony on the clinical basis for each prescription category if the attack is serious enough to warrant it.
[!TIP] If defense files a motion in limine to limit pharmacy lien recovery to Medicare rates, prepare to argue the distinction between an insured plaintiff with a contractual write-down under Howell and an uninsured lien patient whose lien amount is the actual charge — this is the primary legal rebuttal.
[!KEY] The financial bias attack collapses when you can show that the physician's prescribing decision preceded any pharmacy selection — establish this timeline clearly in the treating physician's deposition before trial.
Pre-Trial Preparation for Pharmacy Lien Defense
Organize the medication record chronologically. Each fill should correspond to a prescription in the medical records. A pharmacy lien that can be tied line-by-line to treating physician prescriptions is substantially harder to attack than one that appears to have appeared from thin air.
Prepare the treating physician on independence. If the case is going to trial with a significant pharmacy lien as part of special damages, the treating physician should be prepared to address the financial relationship question directly and cleanly.
Know the Howell/Corenbaum landscape. If the defense files a motion in limine to exclude the lien amounts or limit them to Medicare rates, you need to be ready to argue the distinction between an insured plaintiff with a contractual write-down and an uninsured lien patient.
Document the plaintiff's insurance status. The absence of health insurance coverage for injury-related prescriptions is foundational. Make sure it's in the record.
For more on managing pharmacy liens through litigation, visit for attorneys.
[!KEY] Documenting the plaintiff's uninsured status for injury-related prescriptions is foundational to defeating the inflated-charges attack — it distinguishes your client from an insured plaintiff with contractual write-downs and establishes the lien amount as the actual, reasonable charge.
Related Resources
Frequently Asked Questions
Can defense counsel argue that pharmacy lien charges are inflated special damages under Howell?
Defense counsel regularly makes this argument. The key distinction is that Howell addressed insured plaintiffs whose medical bills were written down by contract with insurance. A pharmacy lien patient is uninsured for injury-related prescriptions — the lien amount is the actual charge, not an inflated list price subject to a contractual write-down. Whether Howell limits lien recovery in a specific case depends on the facts and the trial court, but the legal distinction between an insured write-down and an uninsured lien patient is the primary rebuttal.
How do I counter the argument that the prescribing physician had a financial relationship with the pharmacy?
Pharmacy lien providers do not pay referral fees to physicians. The prescribing decision is the physician's independent clinical judgment; the pharmacy selection is a separate decision made by the patient and the attorney. Prepare the treating physician to address the financial independence question directly in deposition or at trial — confirming no compensation relationship with any pharmacy lien provider and that prescriptions reflect clinical findings documented in the treatment record.
What evidence most effectively defeats the manufactured treatment argument?
A chronological medication record tied line-by-line to physician prescriptions in the medical records. Each fill should correspond to a documented prescription, which corresponds to a documented clinical finding. The timeline — injury date → diagnosis → prescription → fill → follow-up — is the most persuasive evidence that the medications were clinically warranted, not manufactured for litigation purposes.